In three studies, plasma IGF-1 concentrations were calculated using chemiluminescence, which also revealed no major differences in plasma IGF-1 concentrations between OSAHS and control groups (SMD=-0.54, 95% CI = -1.16–0.09, P=0.093). This evidence concerns the gene IGF1 and obstructive sleep apnea syndrome.